$1000 Invested In Centene 15 Years Ago Would Be Worth This Much Today
CNCMorgan Stanley Initiates Coverage On Centene with Overweight Rating, Announces Price Target of $70
CNCBreaking Down Centene: 5 Analysts Share Their Views
CNCBarclays Downgrades Centene to Equal-Weight, Lowers Price Target to $65
CNCIf You Invested $100 In This Stock 15 Years Ago, You Would Have This Much Today
CNCElizabeth Warren Says Jeff Bezos And Elon Musk 'Are Popping Champagne' As House Passes Trump's 'Big, Beautiful Bill' She Calls A Handout To Billionaires
CNCSen. Elizabeth Warren (D-Mass.) accused billionaires Jeff Bezos and Elon Musk of celebrating after House Republicans passed President Donald Trump's sweeping tax legislation, calling it the "greatest transfer of wealth from the poor to billionaires" in U.S. history.
If You Invested $1000 In This Stock 20 Years Ago, You Would Have This Much Today
CNCHow Do Investors Really Feel About Centene?
CNCReported Friday, Arizona Complete Health Secures Six-Year Contract To Lead Arizona Long Term Care Medicaid Services
CNCJefferies Maintains Hold on Centene, Lowers Price Target to $61
CNCGuggenheim Reiterates Neutral on Centeneto Neutral
CNCForecasting The Future: 4 Analyst Projections For Centene
CNCBarclays Maintains Overweight on Centene, Lowers Price Target to $84
CNCHere's How Much You Would Have Made Owning Centene Stock In The Last 20 Years
CNCInsurer Centene Reaffirms Annual Profit Guidance, Reports Better Than Expected Q1 Earnings
CNCCentene raised its 2025 premium revenue outlook by $6 billion, citing strong Marketplace and Medicare Advantage performance in Q1.
UPDATE: Centene Expects FY25 Adj. EPS Of More Than $7.25 Vs $7.23 Estimate
CNCUPDATE: Centene Expects GAAP FY2025 EPS Of More Than $6.19 Vs $6.23 Estimate
CNCCentene FY2025 expected to be more than $7.25 vs $7.23 Est
CNCCentene FY2025 expected to be more than $6.19 vs $6.23 Est
CNCCentene Q1 Adj. EPS $2.90 Beats $2.54 Estimate, Sales $46.62B Beat $43.36B Estimate
CNCCentene's Earnings: A Preview
CNCHere's How Much $1000 Invested In Centene 20 Years Ago Would Be Worth Today
CNCBaird Maintains Neutral on Centene, Lowers Price Target to $69
CNCGuggenheim Initiates Coverage On Centene with Neutral Rating
CNCThis Centene Analyst Is No Longer Bearish; Here Are Top 5 Upgrades For Tuesday
CNCJefferies Upgrades Centene to Hold, Raises Price Target to $64
CNCHere's How Much You Would Have Made Owning Centene Stock In The Last 20 Years
CNCPeering Into Centene's Recent Short Interest
CNCCentene Subsidiary, Meridian Health Plan of Illinois, To Continue Providing Medicare And Medicaid Services For Dually Eligible Members In Illinois
CNCCentene Expects To Reaffirm Its Previously Issued 2025 Adjusted EPS Guidance Of Greater Than $7.25 (Est $7.23) - Filing
CNCHere's How Much You Would Have Made Owning Centene Stock In The Last 20 Years
CNCSuperior HealthPlan, A Company Of Centene To Provide $200,000 Through Annual Grant Program
CNCCentene Plans To Reaffirm 2025 Full Year Adjusted EPS Guidance Floor Of Greater Than $7.25, Est $7.23
CNCIf You Invested $100 In This Stock 20 Years Ago, You Would Have This Much Today
CNCA Glimpse Into The Expert Outlook On Centene Through 9 Analysts
CNCWells Fargo Maintains Overweight on Centene, Lowers Price Target to $72
CNC(CNC) - Analyzing Centene's Short Interest
CNCHere's How Much You Would Have Made Owning Centene Stock In The Last 15 Years
CNCLooking Into Centene's Recent Short Interest
CNC(CNC) - Analyzing Centene's Short Interest
CNCWells Fargo Maintains Overweight on Centene, Lowers Price Target to $90
CNCCentene's Buckeye Health Plan Awarded Contract To Serve Dual Eligible Medicare And Medicaid Members In Ohio
CNCGeneral Motors And 3 Other Stocks Insiders Are Selling
CNCUS stock futures traded higher ahead of the much-awaited interest rate decision from the Federal Reserve. Investors, meanwhile, focused on some notable insider trades.